Q1 2025 Earnings May 6, 2025 Forward-looking Statements / Legal Disclaimer $4.10 BILLION Management of Energy Transfer LP (ET) will provide this presentation in conjunction with ET's 1st quarter 2025 earnings conference call. On the call, members of management may make statements about future events, outlook and expectations related to Sunoco LP (SUN), USA Compression Partners, LP (USAC), and ET (collectively, the Partnerships), and their subsidiaries and this presentation may contain statements about futur ...

Core Insights - Brookdale Senior Living Inc. reported solid first quarter results for 2025, indicating significant momentum in meeting the needs of the aging population and positioning for accelerated growth [3][4][6] - The company raised its annual guidance for RevPAR and Adjusted EBITDA, reflecting an improved outlook for 2025 [14][18] Financial Performance - Resident fees increased to $777.5 million in Q1 2025 from $744.2 million in Q1 2024, a rise of 4.5% [4][9] - Adjusted EBITDA rose to $124.1 million, up 27.2% from $97.6 million in the prior year [4][36] - Net loss for Q1 2025 was $65.0 million, compared to a loss of $29.6 million in Q1 2024, marking a 119.7% increase in loss [4][9] Operational Metrics - Weighted average occupancy improved to 79.3% in Q1 2025 from 77.9% in Q1 2024, an increase of 140 basis points [4][5] - RevPAR increased to $5,090, up 4.9% from $4,854 in the previous year [4][5] - Same community operating income increased by 7.6% year-over-year [6] Liquidity and Cash Flow - Total liquidity as of March 31, 2025, was $306.0 million, down $83.3 million from December 31, 2024, primarily due to cash used for acquisitions [11] - Net cash provided by operating activities improved to $23.4 million from a negative $1.1 million in the prior year [8][10] - Adjusted Free Cash Flow for Q1 2025 was $3.8 million, a significant improvement from a negative $26.3 million in Q1 2024 [8][41] Strategic Transactions - In February 2025, the company acquired 30 previously leased communities for $310.0 million, funded through mortgage debt and cash [12] - The company settled its remaining outstanding prepaid stock purchase contracts in March 2025, delivering over 29 million shares of common stock [13] 2025 Guidance - The company revised its full-year 2025 guidance for RevPAR growth to a range of 5.00% to 5.75% and Adjusted EBITDA to $440 million to $450 million [18]

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC) today announced first quarter 2025 results from continuing operations. First Quarter 2025 Financial Highlights: Operating cash flows provided by continuing operations of $21 million Sales of $712 million, a 7% increase compared to the fourth quarter of 2024Gross profit, as a percentage of sales, of 19.9%Adjusted Gross Profit, as a percentage of sales, of 21.5%Net income from continuing operations of $8 millionAdjusted EBITDA of $36 millio ...

HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended March 31, 2025. Net Loss of $(30.4) million, or $(0.57) per diluted shareAdjusted Net Loss of $(50.3) million, or $(0.94) per diluted shareAdjusted EBITDA of $10.1 millionRepurchased $51 million of common stock, or 3.6 million shares, during the first quarterWyoming refinery returned to full crude operations one month ahead of schedule ...

Produced 2,212 vehicles in Q1, excluding over 600 vehicles in transit to Saudi Arabia for factory gating Delivered 3,109 vehicles in Q1; up 58.1% compared to Q1 2024 Q1 revenue of $235.0 million GAAP net loss per share of $(0.24); non-GAAP net loss per share of $(0.20) Ended the quarter with approximately $5.76 billion in total liquidityNEWARK, Calif., May 6, 2025 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced electric vehicles, today announced financial results for it ...

LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Results Management Commentary "2025 got off to a strong start, as first quarter revenue came in at $113 million, up 5% on a constant currency basis, and adjusted EBITDA came in at $11 million, up 20% versus prior year," s ...

Core Viewpoint - InnovAge Holding Corp. reported strong revenue growth but faced increased losses in its fiscal third quarter ended March 31, 2025, indicating challenges in cost management despite a growing participant base [2][3]. Financial Results - Total revenues for the third quarter reached $218.1 million, a 13.0% increase from $193.1 million in the same quarter of the previous year [3][22]. - Loss Before Income Taxes was $11.1 million, up 72.6% from a loss of $6.4 million in the prior year [3][22]. - Net loss was $11.1 million, compared to a net loss of $6.2 million in the same quarter of the previous year, with a net loss margin of 5.1%, an increase of 1.9 percentage points [3][22]. - Adjusted EBITDA was $10.8 million, significantly up from $3.0 million in the same quarter of the previous year, with an adjusted EBITDA margin of 4.9% [3][22]. Operational Metrics - The company served approximately 7,530 participants, an increase from 6,820 participants in the same quarter of the previous year [3][10]. - Center-level Contribution Margin was $40.7 million, a 19.9% increase compared to $34.0 million in the same quarter of the previous year [3][22]. Cash and Debt Position - As of March 31, 2025, InnovAge had $60.5 million in cash and cash equivalents and $41.3 million in short-term investments, with total debt of $77.3 million [3][19]. Full Fiscal Year 2025 Financial Guidance - The company expects total revenues for the fiscal year to be between $815 million and $865 million, with adjusted EBITDA projected between $24 million and $31 million [5][6]. Leadership Changes - Dr. Richard Feifer, the Chief Medical Officer, departed the company effective April 25, 2025, to pursue other opportunities [4].

Core Viewpoint - Gulf Island Fabrication, Inc. reported solid first quarter results for 2025 despite macroeconomic uncertainties, with a focus on strategic actions taken in recent years to maintain financial strength and operational flexibility [4][5]. Financial Performance - Consolidated revenue for Q1 2025 was $40.3 million, a decrease from $42.9 million in Q1 2024. Net income was $3.8 million compared to $6.2 million in the prior year [5][29]. - Adjusted EBITDA for Q1 2025 was $4.5 million, up from $3.7 million in Q1 2024, excluding a prior year gain of $2.9 million from the Fabrication division [5][10]. - The Services division reported revenue of $19.9 million, down 22.2% from the previous year, primarily due to reduced offshore maintenance activity [7][8]. - The Fabrication division saw revenue increase by 20.7% to $20.7 million, driven by higher small-scale fabrication activity [9][10]. Strategic Initiatives - The company is pursuing organic growth initiatives, including a new cleaning and environmental services offering, and has entered into an agreement to acquire certain assets of ENGlobal Corporation, which is expected to enhance its product and service capabilities [4][15][17]. - The total capital commitment for the acquisition of ENG is $4.0 million, with expectations of operating losses in the range of $1.0 to $2.0 million during the integration period [17][18]. Balance Sheet and Liquidity - As of March 31, 2025, the company had cash and short-term investments exceeding $67 million, with total debt of $19 million at a fixed interest rate of 3.0% [13][39]. - The company repurchased 86,364 shares for $0.6 million during the first quarter under its share repurchase program [14]. Market Outlook - The company anticipates a challenging market outlook for the remainder of 2025 due to macroeconomic uncertainties and reduced capital spending by customers in the Gulf of America [4][5].

Core Insights - INNOVATE Corp. reported a consolidated revenue of $274.2 million for Q1 2025, a decrease of 13.0% compared to $315.2 million in Q1 2024, primarily driven by the Infrastructure segment [2][8] - The company experienced a net loss attributable to common stockholders of $24.8 million, or $1.89 per share, compared to a net loss of $17.7 million, or $2.21 per share, in the prior year [2][12] - Adjusted EBITDA for Q1 2025 was $7.2 million, down 43.8% from $12.8 million in Q1 2024, reflecting challenges in both the Life Sciences and Infrastructure segments [2][14] Infrastructure Segment - DBM Global reported Q1 2025 revenue of $264.9 million, a decrease of 14.0% from $307.9 million in the prior year [4][9] - The adjusted backlog for DBM Global increased to $1.4 billion, up from $1.0 billion as of December 31, 2024, indicating strong project acquisition [5][4] - Gross margin improved to 15.6%, an increase of approximately 110 basis points year-over-year, while adjusted EBITDA margin rose to 6.3%, an increase of approximately 40 basis points [4][5] Life Sciences Segment - MediBeacon's Transdermal GFR System received FDA approval, enhancing growth prospects in the Life Sciences segment [3][10] - R2 Technologies reported a revenue of $3.1 million, a 210% increase compared to $1.0 million in the prior year, driven by increased unit sales [10][3] - The Life Sciences segment's adjusted EBITDA was negative at $(8.7) million, a decrease from $(4.2) million in the prior year, primarily due to higher equity method losses from MediBeacon [14][12] Spectrum Segment - The Spectrum segment reported revenue of $6.2 million, slightly down from $6.3 million in the prior year [10][9] - The company is exploring commercial opportunities in datacasting, with expectations to generate revenue by the end of 2025 [10][3] Financial Performance - Total adjusted EBITDA for Q1 2025 was $7.2 million, down from $12.8 million in Q1 2024, primarily due to declines in the Life Sciences and Infrastructure segments [14][12] - The company had cash and cash equivalents of $33.3 million as of March 31, 2025, down from $48.8 million at the end of 2024 [14][30] - The total liabilities increased to $1,036.9 million as of March 31, 2025, compared to $1,034.8 million at the end of 2024 [30][31]

Financial Data and Key Metrics Changes - In Q1 2025, the company generated adjusted EBITDA of $16.6 million and adjusted net income of $4.6 million, compared to adjusted EBITDA of $7.7 million and an adjusted net loss of $3.1 million in the prior year, marking significant improvements in profitability [5][6] - Cost of Goods Sold (COGS) per ton for potash improved by 17% from the 2023 baseline and by 25% from the peak in Q4 2023, coming in at $313 per ton [6] - COGS per ton for Trio was $235, representing a 22% improvement compared to the previous year's first quarter [6] Business Line Data and Key Metrics Changes - Potash production totaled 93,000 tons in Q1 2025, an increase of 6,000 tons year-over-year, with a 40% increase in tons sold despite a 20% decrease in average net realized pricing [11] - Trio achieved a quarterly sales record of 110,000 tons, with an average pricing increase to $345 per ton [7] - The Oilfield Solutions segment generated revenue of $4.4 million with a gross margin of approximately 38% [13] Market Data and Key Metrics Changes - Potash prices increased by $55 per ton and Trio prices by $40 per ton during Q1 2025 due to strong demand and tight supplies [8] - Global potash consumption is returning to a trend line growth of approximately 2% per year, with a balanced outlook heading into the second half of 2025 [9] - U.S. agriculture exports for corn are up by about 25% year-to-date, supporting forecasts of low crop inventories [9] Company Strategy and Development Direction - The company is focused on revitalizing core assets and improving unit economics, which has positively impacted production and profitability [6][10] - The strategy includes maintaining consistent production levels and cost structures to ensure resilience and predictability in operations [32] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potash and agriculture markets, citing beneficial tariff treatments and a weakening dollar supporting U.S. agriculture exports [9][10] - The company anticipates continued improvements in cash flow and reduced COGS per ton, despite broader market uncertainties [16] Other Important Information - The company expects potash production for 2025 to be between 285,000 to 295,000 tons, with Trio production projected at 235,000 to 245,000 tons [12][13] - Capital expenditures for 2025 are guided at $36 million to $42 million, primarily for sustaining capital [15] Q&A Session Summary Question: Potash pricing expectations for Q2 - Management explained that Q2 pricing is projected at around $355 per ton, reflecting a differential of about $43 per ton compared to Q1 pricing, capturing most of the price uptick [20][21] Question: Production volume expectations for the rest of the year - Management indicated that production forecasts are based on recent projects and the Wendover facility, with a focus on maintaining production levels despite potential variability [23] Question: Outlook for Trio cost improvements - Management noted that while cost improvements are expected to moderate, the current cost structure reflects significant operational efficiencies achieved [27][28] Question: Assessment of company performance and focus areas - Management highlighted the importance of maintaining focus on core assets and consistent performance to drive improvements over the next one to two years [30][32] Question: Cash flow generation and capital allocation - Management confirmed that Q2 is typically the best cash flow generation quarter, with discussions on capital allocation becoming more relevant as performance improves [42]